| Product NDC: | 0555-0727 | 
| Proprietary Name: | Estropipate | 
| Non Proprietary Name: | Estropipate | 
| Active Ingredient(s): | .75 mg/1 & nbsp; Estropipate | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0555-0727 | 
| Labeler Name: | Barr Laboratories Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA040135 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 19980123 | 
| Package NDC: | 0555-0727-02 | 
| Package Description: | 100 TABLET in 1 BOTTLE (0555-0727-02) | 
| NDC Code | 0555-0727-02 | 
| Proprietary Name | Estropipate | 
| Package Description | 100 TABLET in 1 BOTTLE (0555-0727-02) | 
| Product NDC | 0555-0727 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Estropipate | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 19980123 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Barr Laboratories Inc. | 
| Substance Name | ESTROPIPATE | 
| Strength Number | .75 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes |